DCF — ST. MARY MEDICAL CENTER
Enterprise Value: $-137.9M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-137.9M
Enterprise Value
$-53.5M
PV of Cash Flows
$-84.5M
PV of Terminal Value
$-136.0M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $378.7M | $-3.2M | -1.0% | $-19.3M | $-17.5M |
| Year 2 | $390.1M | $0.6M | 0.0% | $-15.9M | $-13.2M |
| Year 3 | $401.8M | $4.6M | 1.0% | $-12.4M | $-9.3M |
| Year 4 | $413.8M | $6.8M | 2.0% | $-10.7M | $-7.3M |
| Year 5 | $426.2M | $8.1M | 2.0% | $-10.0M | $-6.2M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-137.9M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$367.7M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.01352088887686858
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5